Glucocorticoids antagonize estrogens by glucocorticoid receptor-mediated activation of estrogen sulfotransferase.
Glucocorticoids and estrogens are two classes of steroid hormones that have essential but distinct physiologic functions. Estrogens also represent a risk factor for breast cancer. It has been suggested that glucocorticoids can attenuate estrogen responses, but the mechanism by which glucocorticoids inhibit estrogenic activity is unknown. In this study, we show that activation of glucocorticoid receptor (GR) by dexamethasone (DEX) induced the expression and activity of estrogen sulfotransferase (SULT1E1 or EST), an enzyme important for the metabolic deactivation of estrogens, because sulfonated estrogens fail to activate the estrogen receptor. Treatment with DEX lowered circulating estrogens, compromised uterine estrogen responses, and inhibited estrogen-dependent breast cancer growth in vitro and in a xenograft model. We further showed that the mouse and human SULT1E1 genes are transcriptional targets of GR and deletion of Sult1e1/Est in mice abolished the DEX effect on estrogen responses. These findings have revealed a novel nuclear receptor-mediated and metabolism-based mechanism of estrogen deprivation, which may have implications in therapeutic development for breast cancers. Because glucocorticoids and estrogens are widely prescribed drugs, our results also urge caution in avoiding glucocorticoid-estrogen interactions in patients.
Gong
Haibiao
H
Center for Pharmacogenetics and Department of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania 15261, USA.
Jarzynka
Michael J
MJ
Cole
Timothy J
TJ
Lee
Jung Hoon
JH
Wada
Taira
T
Zhang
Bin
B
Gao
Jie
J
Song
Wen-Chao
WC
DeFranco
Donald B
DB
Cheng
Shi-Yuan
SY
Xie
Wen
W
D000818:Animals; D001943:Breast Neoplasms / Q000188:drug therapy / Q000201:enzymology / Q000235:genetics / Q000473:pathology; D048708:Cell Growth Processes / Q000187:drug effects / Q000502:physiology; D045744:Cell Line, Tumor; D003907:Dexamethasone / Q000494:pharmacology*; D004789:Enzyme Activation; D004958:Estradiol / Q000494:pharmacology; D004965:Estrogen Antagonists / Q000494:pharmacology; D004967:Estrogens / Q000097:blood; D005260:Female; D006801:Humans; D008099:Liver / Q000187:drug effects / Q000201:enzymology; D051379:Mice; D008810:Mice, Inbred C57BL; D008819:Mice, Nude; D009376:Neoplasms, Hormone-Dependent / Q000188:drug therapy / Q000201:enzymology / Q000378:metabolism / Q000473:pathology; D012333:RNA, Messenger / Q000096:biosynthesis / Q000235:genetics; D011965:Receptors, Glucocorticoid / Q000235:genetics / Q000378:metabolism*; D015238:Sulfotransferases / Q000096:biosynthesis / Q000235:genetics / Q000378:metabolism*; D014158:Transcription, Genetic; D014599:Uterus / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism; D023041:Xenograft Model Antitumor Assays
D004965:Estrogen Antagonists; D004967:Estrogens; D012333:RNA, Messenger; D011965:Receptors, Glucocorticoid; D004958:Estradiol; D003907:Dexamethasone; D015238:Sulfotransferases; C020122:estrone sulfotransferase
Breast Cancer Res Treat. 2002 Jul;74(2):167-76
12186377
Mol Pharmacol. 2005 Aug;68(2):403-13
15872116
Cancer Lett. 2005 Sep 28;227(2):115-24
16112414
Drug Metab Dispos. 1996 Aug;24(8):854-8
8869819
Endocrinology. 1956 Aug;59(2):165-9
13356781
Endocrinology. 1998 Jun;139(6):2905-15
9607801
Mol Pharmacol. 2008 Mar;73(3):891-9
18055760
Biochem Pharmacol. 1998 Feb 1;55(3):313-7
9484797
Ann N Y Acad Sci. 2001 Dec;948:43-50
11795394
Endocrinology. 2001 Dec;142(12):5342-50
11713234
Biochim Biophys Acta. 2004 Jun 7;1654(2):123-43
15172700
Gene. 2001 Jan 10;262(1-2):257-65
11179691
Endocrinology. 2004 Dec;145(12):5485-92
15345672
Endocrinology. 1967 Mar;80(3):423-9
5227344
Steroids. 1999 Oct;64(10):742-51
10498033
Genes Dev. 1998 Oct 15;12(20):3195-205
9784494
Mol Endocrinol. 2003 Jun;17(6):985-93
12690094
J Steroid Biochem Mol Biol. 1995 Oct;55(1):9-15
7577725
Nat Med. 2004 Oct;10(10):1018-21
15459693
Mol Pharmacol. 1982 May;21(3):753-60
6810090
Methods Enzymol. 1996;272:388-401
8791798
J Clin Invest. 1994 May;93(5):2007-13
8182132
Am J Obstet Gynecol. 2004 Apr;190(4):1141-67
15118656
Mol Endocrinol. 2003 Oct;17(10):2070-83
12893882
Diabetes. 1994 Aug;43(8):999-1004
8039608
Mol Endocrinol. 2006 Feb;20(2):279-90
16195250
Cell. 2006 Aug 25;126(4):789-99
16923397
Proc Natl Acad Sci U S A. 2004 Nov 2;101(44):15603-8
15501915
Drug Metab Dispos. 2002 Sep;30(9):997-1004
12167565
Nat Med. 2003 Aug;9(8):1069-75
12847522
Nat Med. 2005 Feb;11(2):153-9
15685171
Endocr Rev. 2005 May;26(3):452-64
15814846
Drug Metab Dispos. 1996 Oct;24(10):1095-101
8894510
Nature. 2000 Jul 27;406(6794):435-9
10935643
J Pharmacol Exp Ther. 1998 Jul;286(1):555-60
9655902
Mol Cell Endocrinol. 1989 Oct;66(2):189-97
2612731
Genes Dev. 1995 Jul 1;9(13):1608-21
7628695
J Pharmacol Exp Ther. 2008 Feb;324(2):612-21
17993606
Endocrinology. 1978 Sep;103(3):716-23
744113
J Biol Chem. 1990 Aug 15;265(23):14030-5
1974254
Steroids. 2005 May-Jun;70(5-7):407-17
15862824
Cancer Res. 2003 Aug 1;63(15):4684-91
12907650
Endocr Rev. 1999 Jun;20(3):253-78
10368771
FASEB J. 2003 Oct;17(13):1849-70
14519664
Mol Endocrinol. 2002 Aug;16(8):1719-26
12145329
Oncol Res. 1997;9(11-12):589-96
9563006
Cancer Res. 2003 Jun 1;63(11):2762-70
12782580
Contraception. 1999 May;59(5):339-43
10494488
Endocr Rev. 2005 May;26(3):322-30
15817672
Mol Endocrinol. 2007 Aug;21(8):1781-90
17536009
J Biol Chem. 2002 Mar 8;277(10):8531-7
11751931
J Biol Chem. 1998 May 1;273(18):10888-92
9556564
N Engl J Med. 2006 Jan 19;354(3):270-82
16421368
Mol Endocrinol. 2005 Jun;19(6):1402-11
15914709
Annu Rev Physiol. 2005;67:285-308
15709960